about
mtDNA haplogroup X: An ancient link between Europe/Western Asia and North America?Central nervous system gangliogliomas. Part 2: Clinical outcomeTenascin-C expression by angiogenic vessels in human astrocytomas and by human brain endothelial cells in vitroIntrathecal treatment of neoplastic meningitis due to breast cancer with a slow-release formulation of cytarabineBinding of lipophilic nutrients to beta-lactoglobulin prepared by bioselective adsorption.Phase II study of everolimus in children and adults with neurofibromatosis type 2 and progressive vestibular schwannomas.Phase II trial of lapatinib in adult and pediatric patients with neurofibromatosis type 2 and progressive vestibular schwannomas.Brainstem corticospinal tract diffusion tensor imaging in patients with primary posterior fossa neoplasms stratified by tumor type: a study of association with motor weakness and outcome.A phase I/II study of carboplatin combined with hyperfractionated radiotherapy for brainstem gliomas.Intensive chemotherapy and bone marrow rescue for young children with newly diagnosed malignant brain tumors.Metastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastoma in children: conclusions from the Children's Cancer Group 921 randomized phase III study.Phase II study of sorafenib in children with recurrent or progressive low-grade astrocytomas.The development of the black blow fly, Phormia regina (Meigen).Carboplatin and vincristine chemotherapy for children with newly diagnosed progressive low-grade gliomas.A phase II trial of a multi-agent oral antiangiogenic (metronomic) regimen in children with recurrent or progressive cancer.The cyclic AMP pathway is a sex-specific modifier of glioma risk in type I neurofibromatosis patients.Atypical teratoid/rhabdoid tumor evolving from an optic pathway ganglioglioma: case studyRefining the staging evaluation of pineal region germinoma using neuroendoscopy and the presence of preoperative diabetes insipidus.Long-term follow-up of children treated for high-grade gliomas: children's oncology group L991 final study report.Long-term survival of children less than six years of age enrolled on the CCG-945 phase III trial for newly-diagnosed high-grade glioma: a report from the Children's Oncology GroupDiagnostic sensitivity of serum and lumbar CSF bHCG in newly diagnosed CNS germinoma.BRAF alterations in primary glial and glioneuronal neoplasms of the central nervous system with identification of 2 novel KIAA1549:BRAF fusion variants.Cumulative incidence of radiation-induced cavernomas in long-term survivors of medulloblastoma.Controversies in the management of intracranial germ cell tumors.Incidence and severity of postoperative cerebellar mutism syndrome in children with medulloblastoma: a prospective study by the Children's Oncology Group.Pre-irradiation chemotherapy in children with high-grade astrocytoma: tumor response to two cycles of the '8-drugs-in-1-day' regimen. A Childrens Cancer Group study, CCG-945.Functional outcome measures for NF1-associated optic pathway glioma clinical trials.Ovarian function in survivors of childhood medulloblastoma: Impact of reduced dose craniospinal irradiation and high-dose chemotherapy with autologous stem cell rescue.Expression of plasma membrane calcium ATPases in phenotypically distinct canine vascular smooth muscle cells.Relapse and outcome patterns of patients with central nervous system mixed malignant germ cell tumors treated without irradiation: Findings from the third international central nervous system (CNS) germ cell tumor (GCT) study.Management of CNS germinoma.Outcome of young children with high-grade glioma treated with irradiation-avoiding intensive chemotherapy regimens: Final report of the Head Start II and III trials.Management of primary intracranial germ cell tumors of childhood.Intractable facial pain associated with a ganglioglioma of the cervicomedullary junction: report of a case.Brain tumors in children: current cooperative and institutional chemotherapy trials in newly diagnosed and recurrent disease.Childhood brain tumors: current status of clinical trials in newly diagnosed and recurrent disease.Prospective neuraxis MRI surveillance reveals a high risk of leptomeningeal dissemination in diffuse intrinsic pontine glioma.Survival of infants with primitive neuroectodermal tumors or malignant ependymomas of the CNS treated with eight drugs in 1 day: a report from the Childrens Cancer Group.A method of correcting for linear drift in computed tomography brain scans.Growth rates of a human colon adenocarcinoma cell line are regulated by the milk protein alpha-lactalbumin.
P50
Q24539845-3201C8F2-66B2-45A9-8A77-525BFC44E513Q28256716-2C11534A-41F3-4CD6-8E6B-14DD9FD84663Q28272404-60462074-3646-41CE-AB1D-7C7D271F7B0AQ28346742-65B8AFBB-AAB6-4375-BEC1-74DCDA1FC353Q30175845-28C073E6-5D65-4579-B5D4-611FF5F2DBB1Q30422022-33295FEC-097B-4F55-BD2C-2717EB5FE0FDQ30450038-FB86E0D9-2AD8-4E5E-B160-F77F12BC3C19Q31141453-7406F311-C3E8-4064-92E8-3607E6F16B0BQ33330066-F3677888-C85C-444B-A6D3-957DD241DA26Q33501442-1D493F34-A304-47E6-871E-48C194C4686FQ33539849-3AC0B4CC-131F-4C50-BA8C-79874E12B086Q34193749-526F28D9-DA88-4ECF-ABFF-C7C357EF1041Q34310240-5709D576-BEAC-4BBB-9920-521BD188F9B2Q34739729-0A056DA5-EE11-41FC-ABAF-ACA4BD0D3837Q34851156-BA1A003D-5F93-42FC-AA70-645D478BCADBQ34859935-19149D25-9F36-4DD7-910C-8DDEE5F6F12CQ35800546-15171347-AC93-4559-B013-351413AAB572Q35800745-2B53FF3F-8546-46F6-9A32-5700DA9772E9Q35925137-8E8E5564-8EAE-4A44-9FD6-E21AAC2E3059Q35972863-61BDD123-174E-4807-ABC1-CD19FD397C96Q35974626-2C987E67-5246-4B0F-9066-2BD705A2656DQ36239628-72A15B6A-8EB9-4F45-823A-B6A34126F38CQ36408884-B05BB5C3-028A-4B4A-B37B-F2924D39B9DCQ36439649-0D02B7AC-BFF8-4AE0-B4AD-8A24A0E29A80Q36690162-90C55ABC-BAE6-4BB5-8787-5CD51C971628Q36698118-CEC34250-B5B6-42C3-8B63-DD560B54AAFFQ37536287-23DC7AF2-4AB8-4BE5-9199-C3DA7EA1E27DQ38262848-F9A4D676-508F-4C08-8309-4D8663D3CFADQ38313081-D8C67E41-E028-4E2A-89EA-8A84A63C49BEQ38520572-64EB4F27-86F2-4EDA-94F7-D9CF2F93DA33Q38539360-76CAFBC2-F90C-4054-8292-B975720629F1Q38873292-D8236395-8152-4FB9-B105-05E062B92492Q39247017-4E340F6C-0EE0-4AAA-9CF6-C7578BED838BQ39563608-7A152DAA-57C7-4EF9-8FCC-ED0057EA21A2Q39728900-B82B3A35-1AA1-4D03-88F1-04F312951824Q39820982-DF408EEA-51ED-4F7D-A87A-8516CBB4D082Q39858154-943F604B-4AB3-4F48-9451-CFEF1DE538C2Q40677842-9291638A-7B81-46D2-B2C3-2B03B23FD485Q40706555-84C68434-DA3E-4E08-9BEC-2B94215E8944Q40757609-0187BE59-6281-4673-8B65-F34CA96BD38E
P50
description
onderzoeker
@nl
researcher (ORCID 0000-0001-9957-6664)
@en
name
J Allen
@ast
J Allen
@en
J Allen
@nl
type
label
J Allen
@ast
J Allen
@en
J Allen
@nl
altLabel
Jeffreyi Allen
@en
prefLabel
J Allen
@ast
J Allen
@en
J Allen
@nl
P106
P31
P496
0000-0001-9957-6664